secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0000914475-24-000140
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine stockholders elect directors, approve say-on-pay, amended equity plan, ratify EY
--------------------------------------------------------------------------------

- All four Class I directors elected: Rastetter, Morrow, Norwalk, Poon; each received >72M votes.
- Advisory say-on-pay passed with ~80.3M for vs 4.3M against.
- Amended 2020 Equity Incentive Plan approved (76.1M for, 9.5M against).
- Ernst & Young ratified as auditor for FY2024 with 84.6M for, 5.5M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/0000914475-24-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/nbix-20240522.htm
  HTML page:      https://secwatch.observer/filing/0000914475-24-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer